BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12601703)

  • 1. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy.
    Shy ME; Hobson G; Jain M; Boespflug-Tanguy O; Garbern J; Sperle K; Li W; Gow A; Rodriguez D; Bertini E; Mancias P; Krajewski K; Lewis R; Kamholz J
    Ann Neurol; 2003 Mar; 53(3):354-65. PubMed ID: 12601703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
    Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
    J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neuropathy caused by proteolipid protein gene mutations.
    Garbern JY; Cambi F; Lewis R; Shy M; Sima A; Kraft G; Vallat JM; Bosch EP; Hodes ME; Dlouhy S; Raskind W; Bird T; Macklin W; Kamholz J
    Ann N Y Acad Sci; 1999 Sep; 883():351-65. PubMed ID: 10586260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing.
    Taube JR; Sperle K; Banser L; Seeman P; Cavan BC; Garbern JY; Hobson GM
    Hum Mol Genet; 2014 Oct; 23(20):5464-78. PubMed ID: 24890387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLP1 gene duplication causes overexpression and alteration of the PLP/DM20 splicing balance in fibroblasts from Pelizaeus-Merzbacher disease patients.
    Regis S; Grossi S; Corsolini F; Biancheri R; Filocamo M
    Biochim Biophys Acta; 2009 Jun; 1792(6):548-54. PubMed ID: 19376225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
    Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
    Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of proteolipid protein into mitochondria but not DM20 regulates metabolism of cells.
    Somayajulu M; Bessert DA; Hüttemann M; Sohi J; Kamholz J; Skoff RP
    Neurosci Lett; 2018 Jun; 678():90-98. PubMed ID: 29729355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability.
    Wang E; Dimova N; Sperle K; Huang Z; Lock L; McCulloch MC; Edgar JM; Hobson GM; Cambi F
    Exp Neurol; 2008 Dec; 214(2):322-30. PubMed ID: 18835559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild phenotype in Pelizaeus-Merzbacher disease caused by a PLP1-specific mutation.
    Osaka H; Koizume S; Aoyama H; Iwamoto H; Kimura S; Nagai J; Kurosawa K; Yamashita S
    Brain Dev; 2010 Oct; 32(9):703-7. PubMed ID: 20022439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolipid protein 1 gene mutation in nine patients with Pelizaeus-Merzbacher disease.
    Wang JM; Wu Y; Wang HF; Deng YH; Yang YL; Qin J; Li XY; Wu XR; Jiang YW
    Chin Med J (Engl); 2008 Sep; 121(17):1638-42. PubMed ID: 19024090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLP1 gene analysis in 88 patients with leukodystrophy.
    Martínez-Montero P; Muñoz-Calero M; Vallespín E; Campistol J; Martorell L; Ruiz-Falcó MJ; Santana A; Pons R; Dinopoulos A; Sierra C; Nevado J; Molano J
    Clin Genet; 2013 Dec; 84(6):566-71. PubMed ID: 23347225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease.
    Laššuthová P; Žaliová M; Inoue K; Haberlová J; Sixtová K; Sakmaryová I; Paděrová K; Mazanec R; Zámečník J; Šišková D; Garbern J; Seeman P
    J Child Neurol; 2014 Jul; 29(7):924-31. PubMed ID: 23771846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive genetic analyses of PLP1 in patients with Pelizaeus-Merzbacher disease applied by array-CGH and fiber-FISH analyses identified new mutations and variable sizes of duplications.
    Shimojima K; Inoue T; Hoshino A; Kakiuchi S; Watanabe Y; Sasaki M; Nishimura A; Takeshita-Yanagisawa A; Tajima G; Ozawa H; Kubota M; Tohyama J; Sasaki M; Oka A; Saito K; Osawa M; Yamamoto T
    Brain Dev; 2010 Mar; 32(3):171-9. PubMed ID: 19328639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Iden DL; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2010 Nov; 58(14):1727-38. PubMed ID: 20629189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolipid protein dimerization at cysteine 108: Implications for protein structure.
    Daffu G; Sohi J; Kamholz J
    Neurosci Res; 2012 Oct; 74(2):144-55. PubMed ID: 22902553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate.
    Appikatla S; Bessert D; Lee I; Hüttemann M; Mullins C; Somayajulu-Nitu M; Yao F; Skoff RP
    Glia; 2014 Mar; 62(3):356-73. PubMed ID: 24382809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional study of novel PLP1 mutations in Chinese patients with Pelizaeus-Merzbacher disease.
    Xie H; Feng H; Ji J; Wu Y; Kou L; Li D; Ji H; Wu X; Niu Z; Wang J; Jiang Y
    Brain Dev; 2015 Sep; 37(8):797-802. PubMed ID: 25491635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.
    Garbern JY; Yool DA; Moore GJ; Wilds IB; Faulk MW; Klugmann M; Nave KA; Sistermans EA; van der Knaap MS; Bird TD; Shy ME; Kamholz JA; Griffiths IR
    Brain; 2002 Mar; 125(Pt 3):551-61. PubMed ID: 11872612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.